Linfoma no Hodgkin de células grandes inmunofenotipo T/NK extraganglionar de tipo nasal (granuloma letal de la línea media) A propósito de un caso
Referencias
1.-Valdez L, Andrade V, Nellen H, Halabe J. Síndrome
destructivo de la línea media. Revista de la Facultad de Medicina
UNAM, México, 2003:46(2): 59-62.
2.-.Wenig B. Undifferentiated
Malignant Neoplasms of the Sinonasal tract. Arch Pathol Lab Med
2009;133:699-712
3.-Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal
Lymphoma: a clínicopathologic anallysis of 58 cases from the Massachusetts
General Hospital. Am J Surg Pathol. 1999;23:1356-1369.
4.-Sandoval
RT, Castañón GJ, Halabe ChJ, Laredo SF, Lifshitz A. Enfoque clínico del
síndrome destructivo de la línea media. Rev Med IMSS
1988; 26: 235-39
5.-Aozasa K, Ohsawa
M, Tajima K, Sasaki R, Maeda H, Matsunaga T, et al.Nationwide
study of lethal mid-line granuloma in Japan: frecuencies of Wegener’s
granulomatosis, polymorphic reticulosis, malignant Iymphoma and other related
conditions. Int J Cancer 1989;
44: 63-66.
6.-Rengifo P L,
Cortez F, Carayhua D, Ontón J,
Moreno M. Linfoma nasal de células t/natural killer. Reporte de un caso.
Dermatología Peruana, 2007;17(2): 115-118. Revista "online": www.revistas.concytec.gob.pe/scielo.
7. McBride P.: Photographs of a case of rapid destruction of the nose and face. J
Laryng and Otol, 1897, 12:64.
8.-Pileri SA, Agostinelli C, Sabattini E, Bacci F,
Sagramoso C, Pileri A, Falini B, Piccaluga PP. Lymphoma
classification: the quiet after the storm. Sem in Diagn Pathol 2011; 28:
113-123.
9.-Gualco G, Domeny-Duarte P, Chioato L, et al. Clinicopathologic and
molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell
lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol. 2011;35:1195–1203.
10.-Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on
Nasal and Related Extranodal Angiocentric T/Natural
Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology.
Am J Surg Pathol 1996; 20: 103-10.
11.- Ferry J. Extranodal Lymphoma. Arch Pathol Lab Med.2008;132:565-578
12.-Barrionuevo C, Zaharia
M, Martinez MT, et al. Extranodal NK/Tcell lymphoma, nasal type: study of clinicopathologic and
prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol.
2007;15:38–44.
13.-Milián MA, Bagán JV, Jiménez Y, Calabuig C . 2001. Linfoma angiocéntrico localizado en paladar. Acta
Otorrinolaringol, España, 2001; 523-526.
14.-Wening B M. Undifferentiated malignant neoplasms of
the sinonasal tract. Arch Pathol Lab
Med. 2009;133:699-712.
15.-Meneses García A, Súchil Bernal L, de la Garza Salazar J,
Gómez González E. Linfomas angiocéntricos centrofaciales de células T/NK.
Aspectos histopatológicos y algunas consideraciones clínicas de 30 pacientes
del instituto Nacional de Cancerología, México. Cir Ciruj 2002;70:
410-16.
16.-Cha
JKC, Wong KF, Jaffe ES, Ralfkiaer E. Aggressive NK-cell lymphoma. In Jaffe ES,
harris NL, Stein H, Vardiman JW eds. World health Organization classification
of tumors: pathology and genetics of tumors hematopoietic and lymphoid tissue. Lyon: IARC Press, 2001; 198-200.
17.-Tao J, Shelat SG, Jaffe ES, Bagg A. Aggressive Epstein-Barr virus-associated,
CD8+, CD30+, CD56+, surface CD3-, NK-like cytotoxic T-cell lymphoma. Am J. Surg
Pathol. 2002; 26: 111-118.
18.-Jaffe
ES, Krenacs L, raffeld M. Classification of cytotoxic T-cell and natural killer
cell lymphomas. Semin. Hematol. 2003; 40: 175-184.
19.-Yoon TY, Lee HT, Chang SH (1999)
Nasal-type T/natural killer cell angiocentric lymphoma, Epstein-Barr
virus-associated, and showing clonal T-cell receptor gamma gene rearrangement.
Br J Dermatol 140:505-508.
20.-Kim TM, Park YH, Lee SY et al. Local tumor invasiveness is more predictive
of survival than International
Prognostic Index in stage I (E)/II(E) extranodal NK/T-cell lymphoma,
nasal-type. Blood 2005; 106: 3785-90.
21.-Kwong
YL, Chan AC, Liang R et al. CD56+ NK lymphomas: clinicopathological features
and prognosis. Br J Haematol 1997; 97: 821-9.
22.-Chan JK, Quintanilla-Martínez L, Ferry Ja. Extranodal
NK/T-cell lymphoma, nasal type. In: swerdlow SH, Campo E, Harris NL et al., teds. WHO Classifications of Tumours of
Haematopoietic and Lymphoid Tissues. Lyon,
France: IARC,
2008; 285-8.
23.-Li S, Feng X, Li T, Zhang S, Zuo Z, lin p, Konoplev S, Bueso-Ramos C, Vega F,
Medeiros J, Yin C. Extranodal NK/T- cell Lymphoma, nasal type. A report of 73
cases at MD Anderson Cancer Center.Am J Surg Pathol 2013;37:14-23
24.-Siu LL, Chan V, Chan JK, et al. (2000) Consistent patterns of allelic loss in
natural cell lymphoma. Am J Pathol 157: 1803-1809.
25.-Sun
HS, Su IJ, Lin YC, et al. (2003) A 2.6 Mb interval on chromosome 6q25.2-q25.3
is commonly deleted in human nasal natural killer/T-cell lymphoma. Br J Haematol 122:590-599.
26.-Quintanilla-Martínez L, Kremer M, Kelelr G, et al.
(2001)
p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell
morphology and advanced disease. Am j Pathol 159:2095-2105.
27.-
Lee J, Suh C, Park YH et al. Extranodal natural killer T-cell lymphoma,
nasal-type; a prognostic model from a retrospective multicenter study. J Clin
Oncol 2006; 24: 612-8.
28.-
Kim SJ, Kim BS, Choi CW et al. Ki-67 expression is predictive of prognosis in
patients with stage I/II extranodal NK/Tcell lymphoma, nasal type. Ann Oncol
2007; 18: 1382-7.
|
